Pozen jumps as Sanofi agrees to sell combined aspirin products
This article was originally published in Scrip
Executive Summary
Sanofi is to commercialize Pozen's investigational, coordinated-delivery tablets combining immediate-release omeprazole, a proton pump inhibitor (PPI), and enteric-coated (EC) aspirin in a single tablet.